DIM (diindolylmethane) benefits: what the research does and doesn't show

The evidence doesn't support DIM, at any dose sold as a supplement, as a treatment for PCOS, uterine fibroids, endometriosis, menopause symptoms, or acne — no human trial has tested it for any of those specifically. What does exist is a small set of human trials measuring DIM's effect on estrogen-related lab markers, mostly in women with a personal or genetic history of hormone-sensitive cancer, plus a couple of trials in cervical cell changes and prostate cancer. Results are mixed, several are null on their main outcome, and none were designed around the conditions DIM is most often marketed for.

What the evidence doesn't support

It doesn't support DIM as a treatment for PCOS, uterine fibroids, endometriosis, hot flashes or other menopause symptoms, or acne. We didn't find a single published human trial testing DIM against any of these specifically — the absence of a trial isn't the same as a trial that found no effect, but it does mean any specific claim about DIM and these conditions is not backed by human research at this time. A 2024 review of ingredients in popular acne supplements found DIM among the most commonly included, without identifying a human trial testing it for acne (PMID 38495547). A related lab-dish study found DIM inhibited an acne-associated bacterium at a concentration far higher than an oral supplement dose would be expected to reach on skin (PMID 35107361) — a laboratory result, not evidence it clears skin.

What the trials found

Estrogen-metabolite ratios, in women. A pilot study gave 19 postmenopausal women with a history of early-stage breast cancer either 108 mg/day of DIM or a placebo for 30 days. DIM significantly increased one urinary estrogen metabolite and cortisol compared with placebo, and the metabolite ratio researchers use as a proxy marker moved 47% in the favorable direction without reaching statistical significance in this small sample (PMID 15623462). A larger, more rigorous 2023 trial — double-blind, placebo-controlled, 60 premenopausal women with an unfavorable baseline ratio — tested 75 mg/day of DIM for 30 days and found no significant improvement in that same primary outcome. A secondary finding, a greater drop in body-fat percentage in the DIM group, was described by the study's own authors as needing further research, not a confirmed effect (PMID 36111381). Put together: DIM has moved a lab marker in a favorable direction in small trials, but the largest and most controlled of them was null on that exact question.

Breast tissue density, in women at high genetic risk. A one-year study gave 100 mg/day of DIM to 23 women carrying a high-risk BRCA gene mutation. Breast tissue density on MRI dropped slightly but statistically significantly, and estradiol and testosterone levels fell, compared with an untreated comparison group tracked over the same year. Side effects were mild. But the DIM group itself had no placebo arm — everyone in it knew they were taking DIM — so the study can't rule out other explanations for the change (PMID 32458980).

Cervical cell changes. A randomized trial gave 64 women with biopsy-confirmed moderate-to-severe cervical cell changes (already scheduled for a standard surgical procedure) either oral DIM, at about 2 mg/kg a day, or placebo, for 12 weeks. DIM was well tolerated — mild nausea in 3% of the DIM group, no organ toxicity — but there was no statistically significant difference from placebo on any outcome measured, even though a high proportion of both groups improved (PMID 19939441). That's a clear null result on the trial's own terms.

Men and prostate tissue. A single-arm study gave 28 men with localized prostate cancer a high-dose (450 mg/day), specially formulated DIM regimen for at least two weeks before scheduled surgery. DIM reached measurable levels in prostate tissue, and most patients showed changes in androgen-receptor activity and a drop in PSA. With no placebo or untreated comparison group, though, the study can't show how much of that change DIM itself caused, versus normal fluctuation or the anticipation of surgery (PMID 27069550).

A broader caution. A review of cruciferous vegetables and cancer risk summarized the field this way: DIM and its precursor change urinary estrogen-metabolite patterns in women, but it doesn't establish whether that translates into a lower risk of hormone-sensitive cancer in humans — and some experimental research has found the opposite, tumor-promoting effect with prolonged indole exposure (PMID 17317210). That's a reason for caution in either direction, not just optimism.

Questions people ask

What does DIM supplement do?

In the body, it's involved in how estrogen is broken down into different metabolites — see what is DIM (diindolylmethane)? for the chemistry. Small human trials have measured DIM shifting the ratio of those metabolites, with mixed results — the largest, most controlled trial found no significant change in its main outcome. What that shift means for any specific health goal hasn't been established by human research.

What is DIM supplement good for? Is it good for you?

The honest answer, given the trials above, is: it's been studied mainly in specific research populations (women with a history or genetic risk of hormone-sensitive cancer, women with cervical cell changes, men with prostate cancer) for lab and tissue markers, with mostly null or mixed results, and it hasn't been tested at all for the conditions — PCOS, fibroids, menopause, acne — that most retail marketing targets.

Can men benefit from taking DIM supplements?

The only men's trial we found studied a high-dose, specially formulated regimen in men with prostate cancer before surgery, with no placebo comparison. It found tissue-level and lab changes but can't establish that DIM caused a meaningful health benefit. There's no trial of DIM in men without prostate cancer for any other men's health goal.

Is DIM supplement good for fibroids, endometriosis, or PCOS?

We found no published human trial testing DIM for uterine fibroids, endometriosis, or PCOS. That's an absence of evidence, not evidence that it doesn't work — but it means any claim connecting DIM to these conditions isn't backed by a trial that actually tested it.

Is DIM supplement good for menopause?

No trial we found tested DIM against menopause symptoms such as hot flashes. The closest available research measured lab markers (estrogen metabolites, breast density) in postmenopausal or high-genetic-risk women, not symptom relief.

Does DIM help with acne?

No human trial has tested it. DIM is a common ingredient in over-the-counter acne supplements, and it inhibited acne-associated bacteria in a lab dish — but at a concentration well above what an oral dose reaches on skin, which doesn't demonstrate a real-world effect.

When to talk to a doctor

PCOS, fibroids, endometriosis, persistent menopause symptoms, and acne that affects your quality of life are all worth discussing with a doctor or dermatologist, who can evaluate and treat the specific condition. DIM is not a treatment for any of them, and nothing in the research above supports using it as a substitute for a diagnosis or a treatment a doctor recommends. If you're pregnant, nursing, have a personal or family history of a hormone-sensitive cancer, or take a prescription medication, ask a doctor before adding any supplement that's proposed to affect hormone metabolism — see DIM and medications: what to check and who should not take DIM? for specifics.